Unternehmen Global Blood Therapeutics, Inc.
Aktien
A14YE6
US37890U1088
GBT
Biotechnologie
Kurzporträt
Mitarbeiterzahl: 457
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | - | |
Chief Tech/Sci/R&D Officer | 63 | 01.05.21 | |
Corporate Officer/Principal | - | - | |
Jung Choi
PRN | Corporate Officer/Principal | 54 | 01.04.15 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 67 476 179 | 63 970 515 ( 94,80 %) | 0 | 94,80 % |
Unternehmenskontakt
Global Blood Therapeutics, Inc.
181 Oyster Point Boulevard
94080, South San Francisco
+650 741 7700
http://www.gbt.com/Sektor
% 1. Jan. | Kap. | |
---|---|---|
-1.88% | 41.35 Mrd. | |
+42.15% | 40.38 Mrd. | |
+1.21% | 39.05 Mrd. | |
-14.19% | 26.67 Mrd. | |
+1.76% | 24.07 Mrd. | |
-24.50% | 18.36 Mrd. | |
-4.14% | 11.68 Mrd. | |
+21.11% | 11.6 Mrd. | |
+7.77% | 11.15 Mrd. |